kynurenic acid has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brotchie, JM; Crossman, AR; Mitchell, IJ; Sambrook, MA | 1 |
| Crossman, AR; Graham, WC; Robertson, RG; Sambrook, MA | 1 |
| Bezard, E; Bioulac, B; Boraud, T; Gross, CE | 1 |
| Bezard, E; Bioulac, B; Gross, CE | 1 |
4 other study(ies) available for kynurenic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Brain Mapping; Callitrichinae; Dominance, Cerebral; Dose-Response Relationship, Drug; Globus Pallidus; Kynurenic Acid; Male; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Reserpine; Synaptic Transmission | 1991 |
Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Dizocilpine Maleate; Female; Globus Pallidus; Infusion Pumps; Kynurenic Acid; Macaca fascicularis; Parkinson Disease, Secondary | 1990 |
Presymptomatic revelation of experimental parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Disease Models, Animal; Kynurenic Acid; Macaca; Parkinson Disease | 1997 |
Glutamatergic compensatory mechanisms in experimental parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agonists; Kynurenic Acid; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Receptors, Glutamate; Substantia Nigra | 1998 |